EPA is generally the better choice if your primary concern is cholesterol, because it lowers triglycerides without raising LDL cholesterol. DHA also lowers triglycerides effectively, but it tends to push LDL cholesterol up by a few percentage points. The difference matters most for people already at risk for heart disease, where any increase in LDL can work against the benefits of triglyceride reduction.
How EPA and DHA Affect LDL Differently
The clearest distinction between these two omega-3s is what they do to LDL, often called “bad” cholesterol. In head-to-head comparisons, DHA raises LDL cholesterol by about 2.6% on average, while EPA either has no effect or slightly decreases it (around a 0.7% reduction). That gap may sound small in percentage terms, but for someone with already elevated LDL, it can be clinically meaningful.
Prescription omega-3 products illustrate this well. Pure EPA formulations show no significant change in LDL compared to placebo and actually reduce apolipoprotein B (a protein that tracks closely with heart disease risk) by about 9%. Products containing both EPA and DHA, on the other hand, have been shown to increase LDL by as much as 49% in patients with very high triglycerides. That’s a dramatic difference, and it’s driven primarily by DHA’s effect on how the liver processes LDL particles.
The mechanism behind this: DHA increases both the production and breakdown of LDL particles in the bloodstream. It speeds up LDL turnover, which results in higher circulating LDL levels even though the particles themselves may be less harmful individually.
DHA’s Advantage: Larger, Less Dangerous LDL
The LDL story isn’t purely negative for DHA. While DHA raises overall LDL numbers, it shifts the type of LDL in a favorable direction. A well-designed crossover study (the ComparED trial) found that compared to EPA, DHA increased average LDL particle size and reduced the proportion of small, dense LDL particles by 3.2%. Small, dense LDL is considered more dangerous because it penetrates artery walls more easily and is more prone to oxidation.
EPA did the opposite, slightly increasing the proportion of small, dense LDL. So the trade-off looks like this: EPA keeps your total LDL number steady, while DHA raises the number but makes each particle less threatening. Which matters more is still debated, but most treatment guidelines focus on lowering LDL levels rather than changing particle size.
Effects on HDL and Triglycerides
Both EPA and DHA are effective at lowering triglycerides. At high doses (around 3.4 grams per day combined), they can reduce triglycerides by roughly 27% in people with moderately elevated levels. EPA and DHA individually produce similar reductions in the 15% to 20% range at doses of about 4 grams per day, though the response varies with how high your triglycerides are to begin with.
Where they diverge again is HDL, or “good” cholesterol. DHA consistently raises HDL more than EPA does. In a pooled analysis of trials, DHA increased HDL by about 7.3% compared to just 1.4% for EPA, a net difference of nearly 6 percentage points. One study in healthy adults found that 3.6 grams of DHA per day raised HDL significantly, while the same dose of EPA produced no HDL change at all. For people whose cholesterol profile includes low HDL alongside high triglycerides, DHA has a clear edge on this specific measure.
Heart Disease Outcomes Tell a Clearer Story
The strongest argument for EPA comes from cardiovascular outcome data. The REDUCE-IT trial tested high-dose pure EPA (4 grams daily) in over 8,000 patients already on statins who had elevated triglycerides. The result was a 25% reduction in major cardiovascular events, including heart attacks, strokes, and cardiovascular death. The number needed to treat was 21, meaning for every 21 patients treated, one major event was prevented.
A comparable trial called STRENGTH tested a combined EPA and DHA formulation at similar doses in a similar patient population. It found no significant reduction in cardiovascular events compared to placebo. The trial was actually stopped early for futility.
There are debates about whether the difference between these trials came down to EPA versus DHA, or to other factors like the type of placebo used. But the contrast is striking: the only omega-3 formulation with strong evidence of preventing heart attacks and strokes is pure EPA at high doses.
What the Guidelines Recommend
The American Heart Association supports prescription omega-3 products at 4 grams per day (containing EPA plus DHA, or EPA alone) specifically for lowering very high triglyceride levels. For people with existing coronary heart disease, the recommendation is about 1 gram per day of EPA plus DHA, preferably from eating oily fish. The AHA does not recommend omega-3 supplements for people without elevated cardiovascular risk.
The distinction between prescription and over-the-counter products matters here. Prescription omega-3s are manufactured to pharmaceutical standards with verified dosing. Store-bought fish oil capsules vary widely in their actual EPA and DHA content, and the doses used in clinical trials (3 to 4 grams of omega-3s daily) would require taking a large number of standard supplement capsules.
Choosing Between EPA and DHA
If your LDL is already high or borderline high, EPA is the safer pick. It won’t raise your LDL, it modestly reduces apolipoprotein B, and it has the only proven cardiovascular outcomes data behind it. This is especially relevant if you’re already taking a statin, since adding DHA could partially counteract the LDL-lowering effect you’re working to achieve.
If your main concern is low HDL combined with high triglycerides and your LDL is well controlled, DHA’s ability to raise HDL and shift LDL toward larger, less harmful particles could be beneficial. Some people take a combined EPA and DHA product for this broader lipid profile improvement, understanding the trade-off on LDL numbers.
For most people asking this question, though, the practical answer leans toward EPA. It improves the lipid markers that matter most without introducing the LDL increase that makes DHA a complicated choice for anyone already managing cholesterol.